VANCOUVER, BC, Aug. 31, 2021 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in advanced proprietary technology and research in psychedelics, today announced its financial results for the three and twelve months ended May 31, 2021. All amounts are stated in Canadian dollars unless otherwise indicated. Business Highlights Commenced the…

Source

Previous articleMindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes
Next articleGlow Time: PsychLight Brings a Powerful Tool to Psychedelic Research